Combination of chimeric antigen receptor therapy and amino pyrimidine derivatives
US-2018140602-A1 · May 24, 2018 · US
Porter David L was listed as an assignee on 1 patent publication in 2018.
| Metric | Value |
|---|---|
| Company | Porter David L |
| Year | 2018 |
| Patents | 1 |
Representative publications for Porter David L in 2018.
Most common classification codes for Porter David L in 2018.
| CPC | Patents |
|---|---|
| A61K2035/124 | 1 |
| A61K2039/505 | 1 |
| A61K2039/545 | 1 |
| A61K2239/31 | 1 |
| A61K2239/38 | 1 |
Navigate to parent entity pages.